office-workplace-table-with-SaasS-reports

Revenue-Based Financing vs. Venture Debt: A Guide for B2B SaaS Companies ($1M to $3M ARR)

At $1 million to $3 million in ARR, founders frequently weigh revenue-based financing against venture debt and aren’t always clear on how they differ. This guide breaks the two down side by side, from how each is sized to what they mean for your cap table, so you can tell which fits your business.

Q1. What’s the difference between venture debt and revenue-based financing?

Venture debt usually carries a fixed repayment schedule and covenants tied to your last round, and it repays on schedule regardless of how revenue performs. Revenue-based financing instead repays as a percentage of recurring revenue, so the pace adjusts if performance changes, and it does not touch the cap table, which suits recurring-revenue software businesses. In both cases the full amount borrowed still has to be repaid. Novel Capital’s Upfront Capital brings the revenue-based model to B2B software and tech companies.

Q2. What should I look for when comparing revenue-based financing options for a SaaS business?

When comparing revenue-based financing options for a SaaS business, look at how the amount is sized (revenue and gross margin versus a flat number), whether there are warrants or equity components, minimum draw requirements, prepayment penalties, and covenants. The most founder-friendly options avoid warrants and preserve ownership entirely. Novel Capital sizes Upfront Capital to 15% to 20% of gross profit margin for B2B software companies, with no warrants and no equity given up.

Q3. Why would I choose revenue-based financing over venture debt?

If preserving your cap table matters and you would rather avoid warrants tied to a recent round, revenue-based financing is generally the more direct fit for a recurring-revenue software business. Because it is sized to recurring revenue and gross margin rather than your last raise, it does not depend on having recently closed a round. Novel Capital’s Upfront Capital works this way for B2B software and tech founders.

Q4. Does revenue-based financing dilute ownership the way an equity round does?

No. Revenue-based financing is non-dilutive, so you do not give up equity or ownership to access it. Repayment is a percentage of revenue, and the obligation is to repay the total amount drawn, not to hand over a stake in the company. Novel Capital’s Upfront Capital takes no warrants and no equity, and is built for B2B software and tech companies.

Related Posts

Debt, Equity, or Both? A Cost of Capital Framework for Founders

Every founder eventually asks some version of the same question: should I raise equity, take on debt, or do both? Most founders answer it by comparing which instrument looks cheaper on paper. That is the wrong question. The real question is whether the return you can generate on a dollar justifies what that dollar actually costs you. This came up in a recent webinar, From Capital Planning to Capital Execution,

How Long Does Fundraising Take? Where the Six to Twelve Months Actually Goes

Ask a founder how long their raise will take and you will usually hear one month, maybe two, maybe three. Ask again four months in and the answer has changed. Carlos Antequera, our co-founder and CEO, names the pattern this way: because founders are optimistic by nature, they tend to think it happens in the next month, two, three. On average, most fundraising processes run six to twelve months. That

Revenue-Based Financing Eligibility and Sizing for B2B SaaS Companies ($5M+ ARR)

A B2B software company above $5 million in ARR clears most providers’ minimums comfortably, so the live questions are what underwriting actually examines and how much capital that revenue supports. This guide covers the underwriting basis, the published eligibility criteria, the amount available at this revenue band, and how existing debt affects capacity. Novel Capital sizes Upfront Capital to 15% to 20% of gross profit margin, from $100,000 to $2

Financing a B2B SaaS Company Through an Exit Process ($5M+ ARR)

A company above $5 million in ARR planning toward a sale needs capital that behaves predictably across a timeline nobody can forecast, and the terms that matter most are the ones that only come up in a transaction. This guide covers what happens to a facility if the company is acquired, whether draws stay available once a process is underway, how a facility compares with an equity bridge, and how

Related Posts